Displaying 501 - 525 of 1556
Source:
Test
Methodology:
FISH
PDGFB Rearrangement (22q13)
Alternative Name
Platelet-derived growth factor beta
Methodology
FISH
Test Description
Probe(s): PDGFB (22q13.1)
Disease(s):…
Source:
Test
Methodology:
FISH
PDGFRA Amplification
Alternative Name
PDGFR Alpha Amplification
Methodology
FISH
Test Description
Probes: PDGFRA (4q12) | Centromere 4
Disease(s): Brain cancer…
Source:
Test
Methodology:
Molecular
PDGFRa Mutation Analysis
Alternative Name
PDGFR Alpha Mutation Analysis
Methodology
Molecular
Test Description
Bi-directional sequencing of exons 12 and 18 of the…
Source:
Test
Methodology:
FISH
PDGFRA Rearrangement
Alternative Name
PDGFR Alpha Rearrangement
Methodology
FISH
Test Description
Probes: PDGFRA | CHIC2 | FIP1L1 (4q12)
Disease(s): Chronic…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA for NSCLC
Alternative Name
Formerly named PD-L1 22C3 FDA (KEYTRUDA®) for NSCLC
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC 22C3…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for Cervical
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1,…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for ESCC (Esophageal Squamous Cell Carcinoma)
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA
Alternative Name
PD-L1, 22C3 FDA (KEYTRUDA®) for Gastric/GEA
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck)
Alternative Name
PD-L1, 22C3, KEYTRUDA
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC 22C3…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for TNBC (Breast)
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 28-8 FDA for NSCLC
Alternative Name
Formerly named PD-L1 28-8 FDA (OPDIVO® + YERVOY®) for NSCLC
Methodology
Immunohistochemistry (IHC)
Test Description
PD-L1 IHC…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC
Alternative Name
PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/Esophageal Adenocarcinoma
Methodology
Immunohistochemistry (IHC)
Test Description…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 LDT
Methodology
Immunohistochemistry (IHC)
Test Description
Programmed cell death ligand 1 (PD-L1) is a transmembrane protein involved in cellular and humoral immune response regulation. PD-L1…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC
Alternative Name
PD-L1, SP142
Methodology
Immunohistochemistry (IHC)
Test Description
The VENTANA PD-L1 (SP142) Assay is a…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PD-L1 SP263 FDA for NSCLC
Methodology
Immunohistochemistry (IHC)
Test Description
The VENTANA PD-L1 (SP263) assay is a qualitative immunohistochemical assay using rabbit monoclonal anti-PD-L1 clone…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Perforin
Methodology
Immunohistochemistry (IHC)
Test Description
Perforin is a protein found in cytoplasmic granules of cytotoxic T-lymphocytes (CTLs). CTLs bind to cells that express foreign antigens…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Periodic Acid Schiff (PAS) for fungus (PASF)
Methodology
Immunohistochemistry (IHC)
Test Description
Special stain.
Specimen Requirements
A formalin-fixed, paraffin-…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Periodic Acid Schiff (PAS)- HEME
Methodology
Immunohistochemistry (IHC)
Test Description
Special stain.
Specimen Requirements
A formalin-fixed, paraffin-embedded (…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Periodic Acid Schiff (PAS)- Non HEME
Methodology
Immunohistochemistry (IHC)
Test Description
Special stain.
Specimen Requirements
A formalin-fixed, paraffin-embedded…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Periodic Acid Schiff (PAS) with digestion (PASD)
Methodology
Immunohistochemistry (IHC)
Test Description
Special stain.
Specimen Requirements
A formalin-fixed,…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PgR
Alternative Name
Progesterone Receptor
Methodology
Immunohistochemistry (IHC)
Test Description
Progesterone Receptor (PR) belongs to a superfamily of nuclear…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
pHistone H3 (PHH3)
Methodology
Immunohistochemistry (IHC)
Test Description
Phosphohistone H3 (PHH3) is a marker of cells in the late G2-M phase of the cell cycle. It is not expressed in apoptotic…
Source:
Test
Methodology:
Molecular
PIK3CA LDT Mutation Analysis by Sequencing
Alternative Name
PI3K Mutation Analysis
Methodology
Molecular
Test Description
Bi-directional sequencing of PIK3CA exons 1,…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PIT1
Alternative Name
POU1F1, GHF-1, growth hormone factor-1
Methodology
Immunohistochemistry (IHC)
Test Description
PIT1 is a transcription factor critical in the…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
PLAP
Alternative Name
Placental Alkaline Phosphatase
Methodology
Immunohistochemistry (IHC)
Test Description
Normally human Placental Alkaline Phosphatase (PLAP) is…